La consultation comporte 1484 lots.
Original notice title
MARCHE SPECIFIQUE 2026 TOUS MEDICAMENTS ET PRODUITS PHARMACEUTIQUES GCS PHARMA HAUTS DE FRANCE
Opportunity Score
Why this score?
Opportunity
5 / 100
Complexity
80 / 100
Risk factors
This is an award notice for an already concluded contract. No current bidding opportunity exists.
Critical information such as tender value, criteria, and lot details are missing from the notice and not analyzed.
Submission deadline in 4 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Weak opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration 48 MONTH
- Supply of pharmaceutical products (medicines) for healthcare establishments in Hauts-de-France, France.
- Framework agreement for 48 months covering 1484 lots.
Show full summary
This is an award notice for a framework agreement for all medicines and pharmaceutical products for GCS Pharma Hauts de France, awarded by Centre Hospitalier de Valenciennes. The notice covers 1484 lots but only summarized here; full details are in an Excel file.
Risks
This is an award notice for an already concluded contract. No current bidding opportunity exists.
Critical information such as tender value, criteria, and lot details are missing from the notice and not analyzed.
Submission deadline in 4 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Framework agreement (oth-mult) with multiple operators.
Administrative
- Electronic submission required.
- Language: French.
Buyer
Name
Centre Hospitalier de Valenciennes
Location
VALENCIENNES, FRA
Website
Buyer profile
Identifier
26590673500013
Lots (1)
LOT-0001
La consultation comporte 1484 lots.
General lot covering all 1484 lots; full details are provided in an external Excel document.
Location
Duration
Category
Award details
Value note
Show original TED data
Original TED description
Pour des raisons techniques, compte tenu de l'impossibilité de saisir un avis d'attribution portant sur 1484 lots au BOAMP, les opérateurs économiques sont informés que ledit avis d'attribution a été créé au moyen d'un document Excel, disponible à l'adresse suivante en accès libre : https://www.marches-publics.gouv.fr/?page=Entreprise.EntrepriseAdvancedSearch&AllCons&id=3008234&orgAcronyme=x7c (celui-ci comporte toutes les mentions obligatoires devant figurer dans un avis d'attribution).
Procurement Details
- Publication date
- 31 May 2026
- Notice type
- Contract notice — standard
- Languages
- French
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 371902-2026
- Source notice ID
- 7d55f0b6-a8fd-4c50-abf2-59930f614614
Documents (1)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
5 / 100
Complexity
80 / 100
Risk factors
This is an award notice for an already concluded contract. No current bidding opportunity exists.
Critical information such as tender value, criteria, and lot details are missing from the notice and not analyzed.
Submission deadline in 4 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications